Walleye Trading’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-41,400
Closed -$350K – 3990
2026
Q1
$350K Sell
41,400
-15,700
-27% -$172K ﹤0.01% 2794
2025
Q4
$645K Buy
57,100
+42,500
+291% +$527K ﹤0.01% 2644
2025
Q3
$219K Buy
14,600
+5,700
+64% +$83K ﹤0.01% 3310
2025
Q2
$126K Buy
+8,900
New +$159K ﹤0.01% 3487
2024
Q1
– Sell
-7,100
Closed -$304K – 4772
2023
Q4
$304K Sell
7,100
-13,000
-65% -$404K ﹤0.01% 3485
2023
Q3
$523K Buy
20,100
+18,200
+958% +$378K ﹤0.01% 2927
2023
Q2
$45.4K Sell
1,900
-12,400
-87% -$213K ﹤0.01% 3983
2023
Q1
$195K Sell
14,300
-101,000
-88% -$1.61M ﹤0.01% 3521
2022
Q4
$1.6M Buy
+115,300
New +$1.63M ﹤0.01% 1860

Other funds holding BHVN

Walleye Trading's BHVN Position: Q2 2026 in Review

Walleye Trading sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 4,153 shares — an estimated $35.1K sold.

Walleye Trading first reported a position in BHVN in Q1 2023 and held it in 7 quarters. The position peaked at $872K in Q2 2023. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Walleye Trading reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 4,153 Biohaven shares in Q2 2026, an estimated $35.1K.
  • Walleye Trading first reported a position in Biohaven in Q1 2023 and held it in 7 quarters.
  • Walleye Trading's Biohaven position peaked at $872K in Q2 2023.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.